A Pilot Study of Alpha-1-Antitrypsin (AAT) in Steroid Refractory Acute Graft vs Host Disease
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Alpha 1-antitrypsin (Primary)
- Indications Graft-versus-host disease
- Focus Therapeutic Use
- 29 Oct 2018 Status changed from active, no longer recruiting to completed.
- 02 Feb 2018 Results published in the Blood
- 03 Aug 2017 Planned primary completion date changed from 1 Jul 2017 to 1 Sep 2017.